Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Insulet Corporation

PODD
Current price
246.80 USD +1.8 USD (+0.73%)
Last closed 256.23 USD
ISIN US45784P1012
Sector Healthcare
Industry Medical Devices
Exchange NASDAQ
Capitalization 17 607 798 784 USD
Yield for 12 month +50.10 %
1Y
3Y
5Y
10Y
15Y
PODD
21.11.2021 - 28.11.2021

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; and Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts. Address: 100 Nagog Park, Acton, MA, United States, 01720

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

312.27 USD

P/E ratio

42.70

Dividend Yield

Current Year

+2 071 600 000 USD

Last Year

+1 697 100 000 USD

Current Quarter

+597 500 000 USD

Last Quarter

+372 600 000 USD

Current Year

+1 445 700 000 USD

Last Year

+1 159 900 000 USD

Current Quarter

+430 900 000 USD

Last Quarter

+377 100 000 USD

Key Figures PODD

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 389 700 000 USD
Operating Margin TTM 16.03 %
Price to Earnings 42.70
Return On Assets TTM 6.80 %
PEG Ratio 6.36
Return On Equity TTM 43.03 %
Wall Street Target Price 312.27 USD
Revenue TTM 2 071 600 000 USD
Book Value 17.26 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 17.20 %
Dividend Yield
Gross Profit TTM 1 445 699 968 USD
Earnings per share 5.78 USD
Diluted Eps TTM 5.78 USD
Most Recent Quarter IV 2024
Quarterly Earnings Growth YOY -6.20 %
Profit Margin 20.19 %

Dividend Analytics PODD

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Dividend History PODD

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
Dividend CAGR 3Y
Dividend CAGR 5Y
Dividend CAGR 10Y
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
Forward Annual Dividend – USD
Last Split Factor
Payout Ratio
Last Split Date

Stock Valuation PODD

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 42.70
Forward PE 60.24
Enterprise Value Revenue 8.71
Price Sales TTM 8.50
Enterprise Value EBITDA 42.59
Price Book MRQ 14.53

Financials PODD

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators PODD

For 52 weeks

160.19 USD 289.46 USD
50 Day MA 266.08 USD
Shares Short Prior Month 2 881 468
200 Day MA 242.84 USD
Short Ratio 2.68
Shares Short 2 398 076
Short Percent 4.56 %